Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose human ADME study of oral 14C-LDE225 in healthy male volunteers
NL-OMON37376Active, not recruiting
- Sponsor
- Novartis
- Start
- Jun 2012
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sonidegib in cancer, sponsored by Novartis. Primary endpoints: Extent of absorption of unchanged drug and total radioactivity, Mass balance and routes of excretion and 10 more. Started Jun 2012; status: active, not recruiting.
02
Drugs
sonidegib
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON37376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37376.